Form 4: Orthopediatrics Corp Director Pelizzon Reports Acquisition of Shares

Director David R. Pelizzon reports acquiring 2,766 shares of Orthopediatrics Corp stock at $0, increasing his direct holdings to 24,547 shares.

Summary

• On May 28, 2024, David R. Pelizzon, a director of Orthopediatrics Corp, acquired 2,766 shares of common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, Pelizzon directly owns 24,547 shares of common stock, which includes 4,640 restricted stock awards.
• Pelizzon may also be deemed the beneficial owner of 6,901,764 shares held by Squadron Capital LLC, where he serves as President and a member of the Managing Committee, but he disclaims beneficial ownership except to the extent of his pecuniary interest.
• The report was filed on May 30, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock acquisition by a director. The acquisition itself could be interpreted as slightly positive, but the document is primarily informational.

Positives

• The director's acquisition of shares could be seen as a positive signal to investors.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the holdings of a director, which is a common occurrence.

Stakeholder Impact

• The transaction may have a minor impact on shareholders' perception of the company.

Key Dates